Cargando…
Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff
BACKGROUND: During the COVID-19 pandemic, federal regulations in the USA for methadone treatment of opioid use disorder (OUD) were temporarily revised to reduce clinic crowding and promote access to treatment. METHODS: As part of a study seeking to implement interim methadone without routine counsel...
Autores principales: | Mitchell, Shannon Gwin, Jester, Julia, Gryczynski, Jan, Whitter, Melanie, Fuller, Douglas, Halsted, Caroline, Schwartz, Robert P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580566/ https://www.ncbi.nlm.nih.gov/pubmed/37848970 http://dx.doi.org/10.1186/s13722-023-00417-7 |
Ejemplares similares
-
Pharmacy-based methadone treatment in the US: views of pharmacists and opioid treatment program staff
por: Wu, Li-Tzy, et al.
Publicado: (2023) -
Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions
por: Sharma, Anjalee, et al.
Publicado: (2016) -
Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service
por: Nordeck, Courtney D., et al.
Publicado: (2022) -
De-Implementing Opioids for Dental Extractions (DIODE): a multi-clinic, cluster-randomized trial of clinical decision support strategies in dentistry
por: Gryczynski, Jan, et al.
Publicado: (2023) -
Process evaluation of a technology-delivered screening and brief intervention for substance use in primary care
por: Ondersma, Steven J., et al.
Publicado: (2016)